NASDAQ:NVCN - Neovasc Stock Price, Price Target & More

$0.0490 0.00 (0.00 %)
(As of 04/22/2018 04:00 PM ET)
Previous Close$0.0490
Today's Range$0.0477 - $0.05
52-Week Range$0.03 - $1.89
Volume48.86 million shs
Average Volume146.31 million shs
Market Capitalization$49.63 million
P/E Ratio-0.13
Dividend YieldN/A
Beta1.2

About Neovasc (NASDAQ:NVCN)

Neovasc logoNeovasc Inc. (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company's segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products. The Tiara is in preclinical/early clinical stage development to provide a minimally invasive transcatheter device for patients experiencing mitral regurgitation (MR) as a result of mitral heart valve disease. The Reducer is an hourglass-shaped, balloon-expandable, stainless steel, bare metal device, which is implanted in the coronary sinus, creating a restriction in venous outflow from the myocardium (the muscular layer of the heart wall). Neovasc produces Peripatch, a biological tissue product that is manufactured from pericardium.

Receive NVCN News and Ratings via Email

Sign-up to receive the latest news and ratings for NVCN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:NVCN
CUSIPN/A
Phone604-270-4344

Debt

Debt-to-Equity Ratio-0.89%
Current Ratio0.77%
Quick Ratio0.75%

Price-To-Earnings

Trailing P/E Ratio-0.13
Forward P/E Ratio-0.54
P/E GrowthN/A

Sales & Book Value

Annual Sales$5.39 million
Price / Sales9.21
Cash FlowN/A
Price / CashN/A
Book Value($0.46) per share
Price / Book-0.11

Profitability

EPS (Most Recent Fiscal Year)($0.37)
Net Income$-22,900,000.00
Net Margins-439.15%
Return on Equity-85.81%
Return on Assets-25.28%

Miscellaneous

Employees147
Outstanding Shares1,012,850,000

How to Become a New Pot Stock Millionaire

Neovasc (NASDAQ:NVCN) Frequently Asked Questions

What is Neovasc's stock symbol?

Neovasc trades on the NASDAQ under the ticker symbol "NVCN."

How were Neovasc's earnings last quarter?

Neovasc Inc. (NASDAQ:NVCN) issued its quarterly earnings data on Tuesday, March, 29th. The medical equipment provider reported ($0.11) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.15) by $0.04. The medical equipment provider earned $2.24 million during the quarter, compared to analyst estimates of $3.26 million. Neovasc had a negative return on equity of 85.81% and a negative net margin of 439.15%. View Neovasc's Earnings History.

When is Neovasc's next earnings date?

Neovasc is scheduled to release their next quarterly earnings announcement on Wednesday, May, 9th 2018. View Earnings Estimates for Neovasc.

What price target have analysts set for NVCN?

2 brokers have issued 12 month target prices for Neovasc's shares. Their predictions range from $0.50 to $2.00. On average, they anticipate Neovasc's share price to reach $1.25 in the next twelve months. View Analyst Ratings for Neovasc.

Are investors shorting Neovasc?

Neovasc saw a increase in short interest during the month of March. As of March 29th, there was short interest totalling 10,229,047 shares, an increase of 121.3% from the March 15th total of 4,622,910 shares. Based on an average daily trading volume, of 85,156,416 shares, the days-to-cover ratio is currently 0.1 days. Approximately 11.4% of the shares of the company are sold short.

Who are some of Neovasc's key competitors?

Who are Neovasc's key executives?

Neovasc's management team includes the folowing people:
  • Paul L. Geyer, Independent Chairman of the Board
  • Fred Colen, President, Chief Executive Officer
  • Christopher Clark, Chief Financial Officer, Corporate Secretary
  • Brian McPherson, Chief Operating Officer
  • Vicki Lee Bebeau, Vice President - Clinical Affairs
  • Randy Lane, Vice President - Research & Development
  • Alexei J. Marko, Director
  • Jane H. Hsiao Ph.D., Independent Director (Age 69)
  • Douglas Glen Janzen, Independent Director
  • William O'Neill, Independent Director (Age 61)

Has Neovasc been receiving favorable news coverage?

News stories about NVCN stock have been trending somewhat positive recently, Accern Sentiment reports. The research firm identifies negative and positive media coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Neovasc earned a coverage optimism score of 0.07 on Accern's scale. They also gave news headlines about the medical equipment provider an impact score of 45.85 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

How do I buy shares of Neovasc?

Shares of NVCN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Neovasc's stock price today?

One share of NVCN stock can currently be purchased for approximately $0.0490.

How big of a company is Neovasc?

Neovasc has a market capitalization of $49.63 million and generates $5.39 million in revenue each year. The medical equipment provider earns $-22,900,000.00 in net income (profit) each year or ($0.37) on an earnings per share basis. Neovasc employs 147 workers across the globe.

How can I contact Neovasc?

Neovasc's mailing address is Suite 5138 - 13562 Maycrest Way, Richmond A1, V6V 2J7. The medical equipment provider can be reached via phone at 604-270-4344 or via email at [email protected]


MarketBeat Community Rating for Neovasc (NVCN)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  185 (Vote Outperform)
Underperform Votes:  157 (Vote Underperform)
Total Votes:  342
MarketBeat's community ratings are surveys of what our community members think about Neovasc and other stocks. Vote "Outperform" if you believe NVCN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NVCN will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Neovasc (NASDAQ:NVCN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for Neovasc in the last 12 months. Their average twelve-month price target is $1.25, suggesting that the stock has a possible upside of 2,451.02%. The high price target for NVCN is $2.00 and the low price target for NVCN is $0.50. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $1.25$3.35$3.35$6.3333
Price Target Upside: 2,451.02% upside544.23% upside544.23% upside313.94% upside

Neovasc (NASDAQ:NVCN) Consensus Price Target History

Price Target History for Neovasc (NASDAQ:NVCN)

Neovasc (NASDAQ:NVCN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/29/2018Canaccord GenuityLower Price TargetBuy -> Buy$1.05 -> $0.50LowView Rating Details
3/29/2018Leerink SwannLower Price TargetOutperform -> Outperform$5.00 -> $2.00HighView Rating Details
4/5/2017Ladenburg ThalmannUpgradeNeutral -> Buy$4.00HighView Rating Details
4/3/2017JMP SecuritiesReiterated RatingOutperform$5.00MediumView Rating Details
(Data available from 4/22/2016 forward)

Earnings

Neovasc (NASDAQ:NVCN) Earnings History and Estimates Chart

Earnings by Quarter for Neovasc (NASDAQ:NVCN)

Neovasc (NASDAQ:NVCN) Earnings Estimates

2018 EPS Consensus Estimate: $0.00
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.00$0.00$0.00
Q2 20181$0.00$0.00$0.00
Q3 20181$0.00$0.00$0.00
Q4 20181$0.00$0.00$0.00

Neovasc (NASDAQ NVCN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2018        
11/14/2017Q3 2017($0.02)($0.06)$1.42 million$1.38 millionViewN/AView Earnings Details
8/10/20176/30/2017($0.02)($0.04)$1.40 million$1.31 millionViewN/AView Earnings Details
5/10/2017Q1 2017($0.08)($0.10)$3.90 million$1.48 millionViewN/AView Earnings Details
3/23/2017Q4 2016$0.47$3.00 million$2.76 millionViewN/AView Earnings Details
11/14/2016Q216($0.06)($0.12)$2.20 million$3.03 millionViewN/AView Earnings Details
8/9/2016Q2 2016($0.09)($0.20)$3.20 million$1.71 millionViewN/AView Earnings Details
4/29/2016Q1 2016($0.10)($0.10)$3.10 million$2.01 millionViewN/AView Earnings Details
3/29/2016Q415($0.15)($0.11)$3.26 million$2.24 millionViewN/AView Earnings Details
11/9/2015Q3 2015($0.10)($0.11)$3.46 million$2.48 millionViewN/AView Earnings Details
8/6/2015Q2 2015($0.10)($0.10)$3.19 million$2.93 millionViewN/AView Earnings Details
5/12/2015Q115($0.05)($0.08)$3.84 million$2.86 millionViewN/AView Earnings Details
3/30/2015Q414($0.06)($0.11)$3.31 million$3.35 millionViewN/AView Earnings Details
11/13/2014Q3 2014($0.08)$3.77 millionViewN/AView Earnings Details
8/13/2014Q2 2014($0.11)$4.03 millionViewN/AView Earnings Details
5/22/2014Q1 2014($0.01)$3.48 millionViewN/AView Earnings Details
4/17/2014Q4 2013($0.04)$3.22 millionViewN/AView Earnings Details
11/20/2013Q3 2013($0.03)$3.50 millionViewN/AView Earnings Details
8/15/2013Q2 2013($0.03)$2.73 millionViewN/AView Earnings Details
5/28/2013Q1 2013($0.04)$2.00 millionViewN/AView Earnings Details
4/29/2013Q4 2012($0.02)ViewN/AView Earnings Details
11/26/2012Q3 2012($0.03)ViewN/AView Earnings Details
8/9/2012Q2 2012($0.03)ViewN/AView Earnings Details
5/29/2012Q1 2012($0.03)ViewN/AView Earnings Details
4/25/2012Q4 2011($0.02)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Neovasc (NASDAQ:NVCN) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Neovasc (NASDAQ NVCN) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 6.86%
Insider Trading History for Neovasc (NASDAQ:NVCN)
Institutional Ownership by Quarter for Neovasc (NASDAQ:NVCN)

Neovasc (NASDAQ NVCN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

Neovasc (NASDAQ NVCN) News Headlines

Source:
DateHeadline
Neovasc (NVCN) Announces Receipt of US$7.1 Million from Exercise of Series C WarrantsNeovasc (NVCN) Announces Receipt of US$7.1 Million from Exercise of Series C Warrants
www.streetinsider.com - April 12 at 10:52 AM
Neovasc Announces Receipt of US$7.1 Million from Exercise of Series C WarrantsNeovasc Announces Receipt of US$7.1 Million from Exercise of Series C Warrants
finance.yahoo.com - April 12 at 10:52 AM
Neovasc Inc (US) (NVCN) Short Interest Up 121.3% in MarchNeovasc Inc (US) (NVCN) Short Interest Up 121.3% in March
www.americanbankingnews.com - April 12 at 1:09 AM
What Should We Expect From Neovasc Inc’s (NASDAQ:NVCN) Earnings In The Years Ahead?What Should We Expect From Neovasc Inc’s (NASDAQ:NVCN) Earnings In The Years Ahead?
finance.yahoo.com - April 11 at 10:44 AM
Neovasc Inc (US) (NVCN) Downgraded by Zacks Investment Research to "Sell"Neovasc Inc (US) (NVCN) Downgraded by Zacks Investment Research to "Sell"
www.americanbankingnews.com - April 10 at 9:44 AM
Neovasc Inc (US) (NVCN) Cut to "Hold" at Zacks Investment ResearchNeovasc Inc (US) (NVCN) Cut to "Hold" at Zacks Investment Research
www.americanbankingnews.com - April 6 at 6:29 PM
Today’s Research Reports on Trending Tickers: AVEO Pharmaceuticals and NeovascToday’s Research Reports on Trending Tickers: AVEO Pharmaceuticals and Neovasc
finance.yahoo.com - April 6 at 10:36 AM
Neovasc Inc (US) (NVCN) Stock Rating Lowered by Zacks Investment ResearchNeovasc Inc (US) (NVCN) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - April 5 at 9:35 AM
Was Neovasc Inc’s (NASDAQ:NVCN) Earnings Growth Better Than The Industry’s?Was Neovasc Inc’s (NASDAQ:NVCN) Earnings Growth Better Than The Industry’s?
finance.yahoo.com - April 1 at 9:59 AM
Neovasc Inc (US) (NVCN) PT Lowered to $0.50 at Canaccord GenuityNeovasc Inc (US) (NVCN) PT Lowered to $0.50 at Canaccord Genuity
www.americanbankingnews.com - March 29 at 2:30 PM
Neovasc Inc (US)s (NVCN) "Outperform" Rating Reaffirmed at Leerink SwannNeovasc Inc (US)'s (NVCN) "Outperform" Rating Reaffirmed at Leerink Swann
www.americanbankingnews.com - March 29 at 12:10 PM
Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2017Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2017
finance.yahoo.com - March 29 at 10:29 AM
Neovasc Inc. to Host Earnings CallNeovasc Inc. to Host Earnings Call
finance.yahoo.com - March 28 at 3:58 PM
Neovasc Inc (US) (NVCN) Sees Large Growth in Short InterestNeovasc Inc (US) (NVCN) Sees Large Growth in Short Interest
www.americanbankingnews.com - March 28 at 2:02 AM
Neovasc (NVCN) Receives Nasdaq Notification Regarding Minimum Market Value Deficiency - StreetInsider.comNeovasc (NVCN) Receives Nasdaq Notification Regarding Minimum Market Value Deficiency - StreetInsider.com
www.streetinsider.com - March 24 at 8:11 AM
Neovasc Inc (US) (NVCN) to Release Earnings on WednesdayNeovasc Inc (US) (NVCN) to Release Earnings on Wednesday
www.americanbankingnews.com - March 24 at 12:52 AM
Neovasc (NVCN) Receives Nasdaq Notification Regarding Minimum Market Value DeficiencyNeovasc (NVCN) Receives Nasdaq Notification Regarding Minimum Market Value Deficiency
www.streetinsider.com - March 23 at 6:23 PM
Neovasc Receives Nasdaq Notification Regarding Minimum Market Value DeficiencyNeovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency
finance.yahoo.com - March 23 at 6:23 PM
Neovasc Announces Year End 2017 Financial Results Conference Call and WebcastNeovasc Announces Year End 2017 Financial Results Conference Call and Webcast
finance.yahoo.com - March 22 at 9:50 AM
Analyzing Neovasc Inc (US) (NVCN) & Danaher (DHR)Analyzing Neovasc Inc (US) (NVCN) & Danaher (DHR)
www.americanbankingnews.com - March 16 at 11:12 PM
Is Neovasc Inc (NASDAQ:NVCN) A Buy At Its Current PE Ratio?Is Neovasc Inc (NASDAQ:NVCN) A Buy At Its Current PE Ratio?
finance.yahoo.com - March 16 at 10:57 AM
Traders News Source: Neovasc, Pipeline Development, Analysts Target Price, Institutional InvestorsTraders News Source: Neovasc, Pipeline Development, Analysts Target Price, Institutional Investors
www.finanznachrichten.de - March 13 at 11:35 AM
Neovasc, Pipeline Development, Analysts Target Price, Institutional InvestorsNeovasc, Pipeline Development, Analysts Target Price, Institutional Investors
finance.yahoo.com - March 13 at 11:35 AM
Neovasc Inc (US) (NVCN) Given Average Recommendation of "Hold" by AnalystsNeovasc Inc (US) (NVCN) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - March 10 at 9:44 AM
Reviewing Illumina (ILMN) and Neovasc Inc (US) (NVCN)Reviewing Illumina (ILMN) and Neovasc Inc (US) (NVCN)
www.americanbankingnews.com - March 10 at 5:12 AM
Neovasc Inc (US) (NVCN) Short Interest Down 37.2% in FebruaryNeovasc Inc (US) (NVCN) Short Interest Down 37.2% in February
www.americanbankingnews.com - March 4 at 1:40 AM
Gagnon Advisors LLC Acquires 610,376 Shares of Neovasc Inc (US) (NVCN)Gagnon Advisors LLC Acquires 610,376 Shares of Neovasc Inc (US) (NVCN)
www.americanbankingnews.com - March 2 at 5:42 PM
Hudson Bay Capital Management LP Buys Shares of 10,355,108 Neovasc Inc (US) (NVCN)Hudson Bay Capital Management LP Buys Shares of 10,355,108 Neovasc Inc (US) (NVCN)
www.americanbankingnews.com - February 28 at 1:47 PM
Neovasc Inc (US) (NVCN) Given Average Rating of "Hold" by AnalystsNeovasc Inc (US) (NVCN) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - February 13 at 9:22 AM
Neovasc to Present at LEERINK Partners 7th Annual Global Healthcare ConferenceNeovasc to Present at LEERINK Partners 7th Annual Global Healthcare Conference
finance.yahoo.com - February 12 at 3:21 PM
Short Interest in Neovasc Inc (US) (NVCN) Drops By 56.6%Short Interest in Neovasc Inc (US) (NVCN) Drops By 56.6%
www.americanbankingnews.com - February 11 at 1:32 AM
Neovascs Reducer nabs elevated reimbursement status in ... - Seeking AlphaNeovasc's Reducer nabs elevated reimbursement status in ... - Seeking Alpha
seekingalpha.com - February 1 at 3:20 PM
Neovasc Announces Receipt of German NUB Status 1 Designation for Neovasc Reducer™ Procedure for Treatment of Refractory AnginaNeovasc Announces Receipt of German NUB Status 1 Designation for Neovasc Reducer™ Procedure for Treatment of Refractory Angina
finance.yahoo.com - February 1 at 3:20 PM
Neovasc Inc (US) (NVCN) and Cerner (CERN) Financial ContrastNeovasc Inc (US) (NVCN) and Cerner (CERN) Financial Contrast
www.americanbankingnews.com - January 31 at 11:16 AM
Neovasc (NVCN) Names Fred Colen as CEO - StreetInsider.comNeovasc (NVCN) Names Fred Colen as CEO - StreetInsider.com
www.streetinsider.com - January 22 at 3:25 PM
Fred Colen Appointed Chief Executive Officer of Neovasc Inc.Fred Colen Appointed Chief Executive Officer of Neovasc Inc.
finance.yahoo.com - January 22 at 8:29 AM
Canaccord Genuity Initiates Coverage on Neovasc Inc (US) (NVCN)Canaccord Genuity Initiates Coverage on Neovasc Inc (US) (NVCN)
www.americanbankingnews.com - January 20 at 6:18 PM
Neovasc Inc (US) (NVCN) Receives Average Recommendation of "Buy" from BrokeragesNeovasc Inc (US) (NVCN) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - January 19 at 10:32 AM
Neovasc Reducer Featured in Live Case at Berlin SymposiumNeovasc Reducer Featured in Live Case at Berlin Symposium
finance.yahoo.com - January 18 at 11:18 AM
Neovasc Reports Tiaras Clinical Case Load AcceleratingNeovasc Reports Tiara's Clinical Case Load Accelerating
finance.yahoo.com - January 8 at 10:30 AM
Neovasc Receives NASDAQ Notification Regarding Minimum Bid RequirementsNeovasc Receives NASDAQ Notification Regarding Minimum Bid Requirements
finance.yahoo.com - January 2 at 5:23 PM
Neovasc Inc (US) (NVCN) Rating Lowered to Strong Sell at ValuEngineNeovasc Inc (US) (NVCN) Rating Lowered to Strong Sell at ValuEngine
www.americanbankingnews.com - January 1 at 3:10 PM
Luminex (LMNX) and Neovasc Inc (US) (NVCN) Head-To-Head ReviewLuminex (LMNX) and Neovasc Inc (US) (NVCN) Head-To-Head Review
www.americanbankingnews.com - December 20 at 7:10 PM
Critical Analysis: Neovasc Inc (US) (NVCN) and The CompetitionCritical Analysis: Neovasc Inc (US) (NVCN) and The Competition
www.americanbankingnews.com - December 20 at 11:28 AM
Head to Head Analysis: Neovasc Inc (US) (NVCN) & Its RivalsHead to Head Analysis: Neovasc Inc (US) (NVCN) & Its Rivals
www.americanbankingnews.com - December 19 at 5:24 PM
Financial Review: Neovasc Inc (US) (NVCN) vs. Its CompetitorsFinancial Review: Neovasc Inc (US) (NVCN) vs. Its Competitors
www.americanbankingnews.com - December 19 at 7:10 AM
Head to Head Contrast: Neovasc Inc (US) (NVCN) & Its CompetitorsHead to Head Contrast: Neovasc Inc (US) (NVCN) & Its Competitors
www.americanbankingnews.com - December 10 at 3:26 AM
Head-To-Head Survey: Neovasc Inc (US) (NVCN) and The CompetitionHead-To-Head Survey: Neovasc Inc (US) (NVCN) and The Competition
www.americanbankingnews.com - December 8 at 3:26 AM
Neovasc Reducer Featured in Live Case at ICI 2017Neovasc Reducer Featured in Live Case at ICI 2017
finance.yahoo.com - December 6 at 10:38 AM
Pre-market Technical Scan on Medical Equipment Equities ... - PR Newswire (press release)Pre-market Technical Scan on Medical Equipment Equities ... - PR Newswire (press release)
www.prnewswire.com - December 5 at 4:31 PM

SEC Filings

Neovasc (NASDAQ:NVCN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Neovasc (NASDAQ:NVCN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Neovasc (NASDAQ NVCN) Stock Chart for Sunday, April, 22, 2018

Loading chart…

This page was last updated on 4/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.